Catalyst Wire Dossier Catalyst Wire Dossier

Viprinex

ancrod · Neurobiological Technologies, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Viprinex, covering 2009-12-23 to 2010-01-12. Get the full timeline:

Most recent: Clinical Trial Update: ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke [Phase 3]

See pricing